One study that did explore the role of LECs in the tumor setting showed that LECs in tumor-draining LNs can cross-present tumor antigens on MHC-I to induce tumor-specific CD8+ T cell apoptosis [23]. This evidence concerns the gene CD8A and neoplasm.